Trial intelligence / Profile preview

Duloxetine versus placebo in elderly women with stress urinary incontinence

2005-001021-28Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in stress urinary incontinence (SUI) and Mixed incontinence (MUI) comparing Yentreve with Placebo (2 arms). Primary endpoint: Change in total incontinence episode frequency from baseline to endpoint. Started Jul 2005; status: completed.

02

Drugs

duloxetine
03

Conditions

stress urinary incontinence (SUI)Mixed incontinence (MUI)

Beyond the preview

Go deeper on 2005-001021-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001021-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call